Cerity Partners’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-129
| Closed | -$1.89K | – | 2429 |
|
|
2024
Q1 | $1.89K | Hold |
129
| – | – | ﹤0.01% | 2284 |
|
|
2023
Q4 | $1.88K | Buy |
+129
| New | +$1.88K | ﹤0.01% | 1848 |
|
|
2023
Q3 | – | Sell |
-129
| Closed | -$1.71K | – | 1736 |
|
|
2023
Q2 | $1.71K | Hold |
129
| – | – | ﹤0.01% | 1625 |
|
|
2023
Q1 | $10.1K | Hold |
129
| – | – | ﹤0.01% | 1833 |
|
|
2022
Q4 | $10.7K | Sell |
129
-1,375
| -91% | -$114K | ﹤0.01% | 1467 |
|
|
2022
Q3 | $138K | Hold |
1,504
| – | – | ﹤0.01% | 1094 |
|
|
2022
Q2 | $225K | Hold |
1,504
| – | – | ﹤0.01% | 1036 |
|
|
2022
Q1 | $365K | Hold |
1,504
| – | – | 0.01% | 671 |
|
|
2021
Q4 | $455K | Hold |
1,504
| – | – | 0.01% | 622 |
|
|
2021
Q3 | $622K | Hold |
1,504
| – | – | 0.01% | 423 |
|
|
2021
Q2 | $461K | Sell |
1,504
-875
| -37% | -$268K | 0.01% | 490 |
|
|
2021
Q1 | $489K | Buy |
2,379
+2,250
| +1,744% | +$462K | 0.01% | 456 |
|
|
2020
Q4 | $26K | Sell |
129
-2,250
| -95% | -$453K | ﹤0.01% | 636 |
|
|
2020
Q3 | $394K | Hold |
2,379
| – | – | 0.02% | 356 |
|
|
2020
Q2 | $590K | Hold |
2,379
| – | – | 0.03% | 261 |
|
|
2020
Q1 | $434K | Hold |
2,379
| – | – | 0.03% | 296 |
|
|
2019
Q4 | $689K | Hold |
2,379
| – | – | 0.04% | 288 |
|
|
2019
Q3 | $649K | Hold |
2,379
| – | – | 0.04% | 285 |
|
|
2019
Q2 | $894K | Hold |
2,379
| – | – | 0.06% | 246 |
|
|
2019
Q1 | $638K | Hold |
2,379
| – | – | 0.04% | 297 |
|
|
2018
Q4 | $506K | Hold |
2,379
| – | – | 0.03% | 315 |
|
|
2018
Q3 | $1.07M | Hold |
2,379
| – | – | 0.07% | 236 |
|
|
2018
Q2 | $965K | Hold |
2,379
| – | – | 0.07% | 238 |
|
|
2018
Q1 | $1.3M | Buy |
2,379
+375
| +19% | +$205K | 0.1% | 201 |
|
|
2017
Q4 | $1.21M | Hold |
2,004
| – | – | 0.08% | 216 |
|
|
2017
Q3 | $923K | Buy |
+2,004
| New | +$923K | 0.07% | 242 |
|